Otis W. Brawley, M.D., chief medical officer of the American Cancer
Society (ACS), visited Hollings Cancer Center (HCC) Oct. 1 to discuss
the future of cancer. Brawley’s visit coincided with an announcement
that HCC will receive a $450,000 grant from the ACS.
This grant program supports new projects undertaken by junior faculty.
Past recipients of these grants have gone on to make important
discoveries in cancer research and treatment around the world.
On behalf of the American Cancer Society Dr. Otis Brawley, left, presents Dr. Andrew Kraft with money to support research.
supporting our young researchers now, we are investing in the next
generation of investigators who have the potential to make important
strides in the fight against cancer,” said Andrew S. Kraft, M.D.,
director of HCC. “It’s important to remember that some of the best
drugs have been developed by researchers who got their start with
American Cancer Society funding. We are so appreciative of our
relationship with a world leader in fighting cancer.”
Brawley addressed physicians and researchers at HCC about the future of cancer.
“Medical research and especially cancer research is in crisis,” said
Brawley. “As funding and support is drying up, it becomes much less
attractive to our best and brightest. We’re extremely grateful for the
public’s continued support that allows us to support these researchers
whose work will benefit us all.”
In March, HCC was awarded designation from the National Cancer
Institute (NCI), a distinction shared by 65 cancer centers in the U.S.
HCC is the only NCI center in South Carolina.
Friday, Oct. 16, 2009